Segall Bryant & Hamill, LLC Heska Corp Transaction History

Segall Bryant & Hamill, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$72.92 - $99.73 $5 Million - $6.84 Million	68,549 New	68,549 $5 Million
Q2 2022 Aug 15, 2022	BUY	$84.23 - $147.57 $257,828 - $451,711	3,061 Added 4.89%	65,722 $6.21 Million
Q1 2022 May 13, 2022	BUY	$122.89 - $171.74 $708,460 - $990,081	5,765 Added 10.13%	62,661 $8.66 Million
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $2.61 Million - $4.45 Million	16,760 Added 41.76%	56,896 $10.4 Million
Q3 2021 Nov 03, 2021	BUY	$228.69 - $274.2 $214,739 - $257,473	939 Added 2.4%	40,136 $10.4 Million
Q2 2021 Aug 12, 2021	BUY	$169.89 - $231.37 $3.18 Million - $4.33 Million	18,707 Added 91.3%	39,197 $9 Million
Q1 2021 May 13, 2021	BUY	$143.93 - $207.3 $2.95 Million - $4.25 Million	20,490 New	20,490 $3.45 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.